Sachiyo Nishida
Overview
Explore the profile of Sachiyo Nishida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hashimoto K, Shindo T, Nishida S, Kobayashi K, Tanaka T, Masumori N
Int J Urol
. 2024 Oct;
32(1):113-115.
PMID: 39428952
No abstract available.
2.
Nishida S, Usui E, Oshio T, Masumori N, Tsuchihashi K
BMC Health Serv Res
. 2024 Oct;
24(1):1183.
PMID: 39367416
Background: Female physicians with children often work fewer hours and take fewer shifts due to additional family responsibilities. This can contribute to a gender pay gap in the medical profession....
3.
Nishida S, Sasaki H, Maeda Y, Koyama M, Miyazawa K, Masumori N
Int J Urol
. 2022 Sep;
29(12):1569-1570.
PMID: 36125901
No abstract available.
4.
Wakamiya T, Hirohashi Y, Murai A, Yanagawa J, Mizue Y, Kubo T, et al.
Biochem Biophys Res Commun
. 2022 Jan;
590:117-124.
PMID: 34974299
The association between type 2 diabetes mellitus and prostate cancer is still under investigation, and the relationship between hyperinsulinemia and prostate cancer stem-like cells (CSCs) is elusive. Here, we investigated...
5.
Matsuki M, Hirohashi Y, Nakatsugawa M, Murai A, Kubo T, Hashimoto S, et al.
Cancer Immunol Immunother
. 2021 Sep;
71(4):905-918.
PMID: 34491407
Immune checkpoint inhibitors (ICIs) are used in cancer immunotherapy to block programmed death-1 and cytotoxic T-lymphocyte antigen 4, but the response rate for ICIs is still low and tumor cell...
6.
Nishida S, Nagaishi K, Motoya M, Kumagai A, Terada N, Kasuga A, et al.
PLoS One
. 2021 Jun;
16(6):e0253646.
PMID: 34166439
Purpose: Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of...
7.
Kobayashi T, Tamura H, Hiragi S, Nishida S, Miyagawa M, Kuroda T, et al.
Hinyokika Kiyo
. 2021 Jun;
67(4):125-132.
PMID: 34107607
Gender equality is one of the most important issues in the promotion of diversity. The participation status of female urologists in academic activities has not been clarified. In the present...
8.
Matsuki M, Inoue R, Murai A, Kubo T, Hashimoto S, Murata K, et al.
Biochem Biophys Res Commun
. 2021 Mar;
552:128-135.
PMID: 33744760
Previously, we investigated gene expression in a high aldehyde dehydrogenase 1 expression (ALDH1) population of urothelial carcinoma (UC) cells as UC cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) and found that...
9.
Nishida S, Shigesawa I, Nagai S, Itoh N, Masumori N
Hinyokika Kiyo
. 2021 Feb;
67(1):47-51.
PMID: 33535298
A 53-year-old man was diagnosed with prostate cancer with multiple bone metastasis. Therefore androgen deprivation therapy was initiated. After treatment with denosumab injection for bone metastasis, hypocalcemia and hypophosphatemia occurred....
10.
Inoue R, Hirohashi Y, Kitamura H, Nishida S, Murai A, Takaya A, et al.
Oncotarget
. 2017 Apr;
8(17):28826-28839.
PMID: 28418868
Cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) are small sub-population of cancer cells that are endowed with higher tumor-initiating ability, self-renewal ability and differentiation ability. CSCs/CICs could be isolated as high...